Mycovia Pharmaceuticals, Inc. Employee Directory
Pharmaceutical ManufacturingNorth Carolina, United States2-10 Employees
Based in Durham, North Carolina, Mycovia Pharmaceuticals, Inc. was formed in 2018 after Viamet Pharmaceuticals was acquired by NovaQuest Capital Management. Its lead product, VIVJOA (oteseconazole) capsules, is an antifungal therapy indicated to reduce episodes of recurrent vulvovaginal candidiasis in females with a history of RVVC who are not of reproductive potential. The therapy has FDA designations, including Qualified Infectious Disease Product status and Fast-Track designation, supporting its development and potential approval.